Provided by Tiger Trade Technology Pte. Ltd.

Summit Therapeutics PLC

17.01
-0.2200-1.28%
Volume:2.68M
Turnover:46.71M
Market Cap:13.11B
PE:-13.60
High:17.85
Open:17.65
Low:16.99
Close:17.23
52wk High:36.91
52wk Low:15.55
Shares:771.00M
Float Shares:129.00M
Volume Ratio:1.26
T/O Rate:2.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2507
EPS(LYR):-0.3080
ROE:-292.49%
ROA:-152.88%
PB:68.21
PE(LYR):-55.23

Loading ...

Has Summit Therapeutics Run Too Far After Its Huge Multi Year Share Price Surge?

Simply Wall St.
·
Dec 10

Russell 2000 Hits Record Highs, Silver Rallies To $60: What's Moving Markets Tuesday?

Benzinga
·
Dec 10

Summit Therapeutics (SMMT) Is Up 6.1% After Cancer Drug Ivonescimab Tops Keytruda Trial Results - What's Changed

Simply Wall St.
·
Dec 09

Summit Therapeutics Grants Stock Options to New Employees

Reuters
·
Dec 06

Summit Therapeutics Currently Down Seven Days Straight, On Pace for Longest Losing Streak Since February 2023 -- Data Talk

Dow Jones
·
Nov 21

Summit Therapeutics Initiated at Peer Perform by Wolfe Research

Dow Jones
·
Nov 19

Summit Therapeutics (SMMT): Evaluating Valuation After Promising HARMONi-A Phase III Survival Results

Simply Wall St.
·
Nov 10

Does Positive Lung Cancer Trial Data Change the Bull Case for Summit Therapeutics (SMMT)?

Simply Wall St.
·
Nov 09

Clear Street Remains a Buy on Summit Therapeutics (SMMT)

TIPRANKS
·
Nov 08

Akeso Inc. Wins China Approval for Ivonescimab in EGFR-Mutated NSCLC

Reuters
·
Nov 08

Summit Therapeutics Says Ivonescimab, Chemotherapy Combination Shows Benefit in Treating Lung Cancer

MT Newswires Live
·
Nov 07

Summit Therapeutics Reports Ivonescimab Plus Chemotherapy Improves Survival in EGFR-Mutated NSCLC Phase III Trial

Reuters
·
Nov 07

Chinese Car Sales in UK Surge 235%

Deep News
·
Nov 07

Truist Financial Sticks to Their Buy Rating for Summit Therapeutics (SMMT)

TIPRANKS
·
Nov 04

Summit Therapeutics Reports Phase III Success for Ivonescimab in EGFR-Mutated NSCLC

Reuters
·
Oct 31

Summit Therapeutics files to sell 26.68M shares of common stock for holders

TIPRANKS
·
Oct 30

Summit Therapeutics Files for Shelf of up to 26.7 Mln Shares of Common Stock by Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Oct 30

Director Yu Xia Reports Acquisition of Summit Therapeutics Inc. Common Shares

Reuters
·
Oct 24

Jaguar Land Rover cyber attack hammers UK car production

cityam
·
Oct 24

Stock Track | Summit Therapeutics Soars 5.33% After Hours on Insider Share Purchases

Stock Track
·
Oct 24